首页> 外文期刊>Current oncology >Chinese Medicine and Biomodulation in Cancer Patients (Part One)
【24h】

Chinese Medicine and Biomodulation in Cancer Patients (Part One)

机译:癌症患者的中医药与生物调节(第一部分)

获取原文
           

摘要

Traditional Chinese Medicine (TCM) may be integrated with conventional Western medicine to enhance the care of patients with cancer. Although it is normally implemented as a whole system, recent reductionist research suggests mechanisms for the effects of acupuncture, herbs, and nutrition within the scientific model of biomedicine. The health model of Chinese medicine accommodates physical and pharmacological interventions within the framework of a body-mind network. A Cartesian split does not occur within this model, but it is necessary to separate the components in order to allow scientific exploration within the restrictions of positivism, reductionism, and controls for confounding factors. Whole systems research is important to evaluate effectiveness when applying the whole model in clinical practice. Scientific analysis enables a mechanistic understanding of the processes that will improve the design of clinical studies and enhance safety. There is enough preliminary evidence to encourage good quality clinical trials to evaluate the efficacy of integrating TCM into Western cancer care.
机译:中药(TCM)可以与常规西药结合使用,以增强对癌症患者的护理。尽管通常将其作为一个整体系统实施,但最近的还原主义者研究提出了在生物医学科学模型内针灸,草药和营养作用的机制。中医健康模型在身心网络的框架内提供物理和药理干预措施。在此模型中不会发生笛卡尔分裂,但是有必要将各个组成部分分开,以便在实证主义,还原主义和混杂因素控制范围内进行科学探索。整个系统研究对于在临床实践中应用整个模型时评估有效性至关重要。科学的分析可以对过程进行机械理解,从而改善临床研究的设计并提高安全性。有足够的初步证据来鼓励高质量的临床试验,以评估将中医纳入西方癌症治疗的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号